Table 1 Age-wise analysis of study subjects
Age group, years | Cases, number | ERpositive, number (%) | PRpositive, number (%) | Both ER and PRpositive, number (%) | Both ER and PRnegative, number (%) |
|---|---|---|---|---|---|
21 to 30 | 09 | 04 (44.4%) | 05 (55.6%) | 04 (44.4%) | 04 (44.4%) |
31 to 40 | 73 | 43 (58.9%) | 37 (50.7%) | 35 (47.9%) | 28 (38.4%) |
41 to 50 | 155 | 86 (55.4%) | 71 (45.8%) | 63 (40.6%) | 61 (39.4%) |
51 to 60 | 117 | 51 (43.6%) | 40 (34.2%) | 39 (33.3%) | 65 (55.6%) |
61 to 70 | 69 | 32 (46.4%) | 23 (33.4%) | 23 (33.3%) | 37 (53.6%) |
71 to 80 | 22 | 15 (68.2%) | 10 (45.5%) | 09 (40.9%) | 06 (27.3%) |
81 to 90 | 05 | 03 (60.0%) | 01 (20.0%) | 01 (20.0%) | 02 (40.0%) |